Efficacy of Topical Azithromycin versus Systemic Doxycycline in Treatment of Meibomian Gland Dysfunction
Background. Ocular surface disease (OSD) is a multifactorial and highly frequent problem. Inadequate or unstable tear film is the main cause, which leads to visual impairments. One of the primary causes of OSD is meibomian gland dysfunction (MGD), with a prevalence of 3.5 to 70%. The aim of this wor...
Saved in:
| Main Authors: | Marwa Aly Zaky, Adel Galal Zaky, Moataz Fayez Elsawy, Kareem Fatehy Shehata, Mohamed Samy Abd Elaziz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2023/4182787 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral azithromycin versus doxycycline in meibomian gland dysfunction: A hospital-based study at Nepal eye hospital
by: Sabita Dhakal, et al.
Published: (2025-04-01) -
A Note on Literature Review Related to “Oral Azithromycin Versus Oral Doxycycline in the Treatment of Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis” [Letter]
by: Safir M, et al.
Published: (2025-02-01) -
Meibomian gland dysfunction
by: Murugesan Vanathi
Published: (2025-02-01) -
Meibomian gland dysfunction in Sjögren's disease
by: Esther N. Anuwa-Amarh, et al.
Published: (2025-08-01) -
Methods of Screening for Meibomian Gland Dysfunction
by: V. N. Trubilin, et al.
Published: (2016-12-01)